As GGT is overexpressed on the membranes of various cancer cells, gGlu-HMRG has been reported as a tool to detect breast cancer [12], lung cancer [9], colorectal tumors [10], head and neck squamous cell carcinoma [7], and prostate cancer [13]. Here, GGT1 is linked to breast cancer.